✦ LIBER ✦

Aripiprazole augmentation to antidepressant therapy in Japanese patients with major depressive disorder: A randomized, double-blind, placebo-controlled study (ADMIRE study)

✍ Scribed by Kamijima, Kunitoshi; Higuchi, Teruhiko; Ishigooka, Jun; Ohmori, Tetsuro; Ozaki, Norio; Kanba, Shigenobu; Kinoshita, Toshihiko; Koyama, Tsukasa

Book ID: 123397813
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 371 KB
Volume: 151
Category: Article
ISSN: 0165-0327
DOI: 10.1016/j.jad.2013.07.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topiramate augmentation in patients with

Topiramate augmentation in patients with resistant major depressive disorder: A double-blind placebo-controlled clinical trial

✍ Arash Mowla; Ehsan Kardeh 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Paroxetine with pindolol augmentation: A

Paroxetine with pindolol augmentation: A double-blind, randomized, placebo-controlled study in depressed in-patients

✍ Christian Geretsegger; Waltraud Bitterlich; Renate Stelzig; Christoph Stuppaeck; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 297 KB

Randomized double-blind placebo-controll

Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study

✍ Gregory H. Pelton; Oliver L. Harper; Matthias H. Tabert; Harold A. Sackeim; Niko 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

## Abstract ## Objective To assess combined antidepressant and cognitive enhancer treatment in elderly patients presenting with depression plus cognitive impairment. ## Methods Twenty‐three elderly (>50 years old) depressed, cognitively impaired (DEP‐CI) patients participated in a pilot study. W

Reboxetine, placebo and paroxetine compa

Reboxetine, placebo and paroxetine comparison in patients with major depressive disorder: A double-blind, placebo- and comparator-controlled study

✍ C.C. Gallen; M.T. Brown 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Is viloxazine an antidepressant? A place

Is viloxazine an antidepressant? A placebo-controlled double-blind study in major depressive disorder presenting in a general hospital

✍ C. Thompson; G. Isaacs 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 596 KB

## Abstract Viloxazine was one of the first of the ‘second‐generation’ antidepressants. Its relative lack of cardiotoxic, anticholinergic, sedative and seizure‐inducing adverse effects suggested its use as an antidepressant in general hospitals where tricyclic antidepressants might be frequently co

A double blind, placebo-controlled pilot

A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression

✍ Paul E. Holtzheimer III; Thomas W. Meeks; Mary E. Kelley; Mustafa Mufti; Raymond 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## Abstract ## Objective Depression in older adults is often associated with cognitive abnormalities and may predict later development of a primary cognitive disorder. This double‐blind, randomized, placebo‐controlled pilot study was designed to assess the safety and efficacy of galantamine augmen